Nitazenes are a group of illicit synthetic opioids. The CDC calls them a novel group of powerful illicit synthetic opioids derived from 2-benzylbenzimidazole that have been linked to overdose deaths in several states [1].
They were never a medicine here. The same CDC report says they were created as a potential pain reliever medication nearly 60 years ago but have never been approved for use in the United States [1].
Two things make this class hard to write about honestly. First, potency is not one number. Lab results put some nitazenes far above fentanyl. They put one of them at about the same level [1]. Second, the published evidence runs out early. Where it does, this page says so. It does not borrow a figure from another drug.
What follows covers what these drugs are and how they reach the supply. It covers what an overdose looks like, what naloxone does, and why a routine test can miss them. It also covers what is known about withdrawal and what treatment involves. Our hub on drug addiction sets out the wider picture.
What Nitazenes Are
They are opioids, and they behave like opioids in the body.
The Drug Enforcement Administration calls the class benzimidazole-opioids. It states that they have a similar pharmacological profile to fentanyl, morphine, and other mu-opioid receptor agonists [2]. That one sentence explains most of the risk. A drug that acts on the same receptor as fentanyl slows breathing the same way. Slowed breathing is what kills people in an opioid overdose.
The word “nitazene” is a nickname, not the name of one chemical. A toxicology report names a specific analog. The ones a reader is most likely to see are isotonitazene, metonitazene, protonitazene and etonitazene [1]. Others keep appearing. The DEA’s scheduling record lists compounds such as N-desethyl etonitazene and N-pyrrolidino isotonitazene, both met only in the last few years [2].
The origin story is short. These drugs were first made and studied for pain relief in the 1950s, by the research labs of a Swiss chemical firm. That work never produced a medically approved product [2]. Nothing in the class is an approved drug product today. The DEA states they are not approved for medical use anywhere in the world [2].
Potency Is Not One Number
This is the point most coverage gets wrong, and the CDC states it carefully.
Laboratory test results indicate that the potency of certain nitazene analogs, naming isotonitazene, protonitazene and etonitazene, greatly exceeds that of fentanyl, whereas the potency of the analog metonitazene is similar to fentanyl [1]. Both halves of that sentence matter. “Greatly exceeds” is the CDC’s phrase. This page does not turn it into a multiplier, because the CDC does not publish one.
So a named analog is not the same thing as the word “nitazene”. In the Tennessee series, the mix shifted from one year to the next. Most of the deaths recorded in 2020 were put down to isotonitazene. In 2021 most were put down to metonitazene [1].
There is a second reason to be careful with potency talk. Nobody buying a drug knows which analog is in it. Nobody knows how evenly it is mixed through a batch, either. A potency figure describes a lab sample, not the thing in front of a person. That is why the advice below is about what to do in an emergency. It is not about grading one drug against another.
How Nitazenes Got Into the US Drug Supply
They arrived recently, and the federal record is specific about when.
Beginning in 2019, the DEA says, this class of synthetic opioids appeared in the United States [2]. Police have met these drugs in solid forms such as powder and pills. They are often mixed with other illicit drugs [2]. The DEA also records that benzimidazole-opioids are commonly co-detected with designer benzodiazepines. It describes that mix as posing significant risk [2].
State data tells the same story from the other end. In Tennessee, every nitazene-involved overdose death found during 2019 to 2021 involved more than one drug [1]. Fentanyl was present in 59.6% of them, methamphetamine in 46.2% and amphetamine in 25.0% [1]. The count itself moved fast. There were no cases in 2019, 10 in 2020 and 42 in 2021 [1].
Scheduling has been chasing the chemistry. Between August 2020 and July 2024 the DEA temporarily controlled 10 benzimidazole-opioids, because they posed a threat to public safety [2]. In October 2025 it added seven more to schedule I. That temporary order runs until October 2027 [2]. Schedule I means the government has found a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision [2]. Our explainer on the DEA drug schedules covers what each schedule means.
What a Nitazene Overdose Looks Like
It looks like an opioid overdose, because that is what it is.
The CDC lists the signs to watch for. They are unconsciousness or inability to awaken; slow or shallow breathing, or difficulty breathing such as choking sounds or a gurgling or snoring noise from a person who cannot be awakened; discolored skin, especially in the nails or lips; and small, constricted pinpoint pupils that do not react to light [3].
The CDC is also clear about the hard call. It may be hard to tell whether a person is high or experiencing an overdose, and if you are not sure, treat it like an overdose [3]. Its four steps are short. Give an overdose reversal medication such as naloxone if one is available, and call 911. Try to keep the person awake and breathing. Lay the person on their side to prevent choking. Stay with them until emergency assistance arrives [3].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Our pages on opioid overdose signs and symptoms and on heroin overdose go through the same picture in more detail.
Where opioid treatment can start in Ohio
The Recovery Village Columbus is our campus in Groveport, Ohio. Its own page lists Medical Detox, Inpatient Rehab for Substance Abuse, Inpatient Rehab for Mental Health, Partial Hospitalization Programming, Intensive Outpatient Programming and Aftercare Planning.
Explore treatment options
Verify your insurance
The Recovery Village Columbus is part of our family of treatment centers. See the Recovery Village Columbus campus.
Naloxone and Nitazenes
Naloxone works, and the CDC’s wording about how much of it may be needed is worth keeping whole.
The CDC’s nitazene report says naloxone has been effective in reversing nitazene-involved overdoses, but that multiple doses might be needed [1]. It adds that, as with fentanyl, multiple naloxone doses might be required because of the potency of nitazene, and that they can be safely administered [1]. The report also says that contacting emergency services is needed. A person who might be overdosing needs immediate medical attention [1].
Two other CDC statements matter here. Naloxone reverses an overdose from opioids when given in time. More than one dose may be required when stronger opioids like fentanyl are involved [4]. Naloxone will not harm someone if they are overdosing on drugs other than opioids. So the CDC says it is always best to use it if you think someone is overdosing [4].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
The hardest number in the Tennessee series is the gap between what naloxone can do and what happened. Naloxone was given to only 12 of the 52 people whose deaths were reviewed, about 23% [1]. Naloxone is sold over the counter in all 50 states, and no prescription is needed [4]. The CDC also asks anyone who gives it to stay with the person until emergency help arrives [4].
Why a Routine Drug Test Can Miss Nitazenes
Standard panels were not built for this class.
The CDC states that nitazenes are an emerging group of highly potent psychoactive substances, tests for which are often not included in standard toxicology panels, and that traditional laboratory panels do not always capture them [1]. In the Tennessee review, most of the deaths turned up in one county. The CDC puts that down to a single forensic center sending blood samples out for a second round of lab testing [1]. Deaths elsewhere in the state are likely to be undercounted [1].
The honest position on detection windows is that this page does not have one. Nitazenes are not among the substances in the federal detection-period tables this site uses. Specialized testing for them exists. What a given program, employer or medical examiner’s office runs is the thing to ask them. A number invented for the gap would be worse than no number, because people act on these figures.
Our page on insurance coverage for rehab covers who pays for the care that follows a positive result, and our page on what rehab costs gives our own published ranges.
Withdrawal: What Is Known and What Is Not
No nitazene-specific withdrawal timeline appears in any of the federal sources cited on this page. That is the honest answer. It is worth saying out loud, because several drugs in this class have no published human course at all.
What can be said rests on the pharmacology. These are mu-opioid receptor agonists [2]. So clinicians treat the withdrawal as opioid withdrawal. SAMHSA’s detoxification protocol describes that syndrome. It states that, unlike alcohol and sedative withdrawal, uncomplicated opioid withdrawal is not life-threatening. It adds that severe vomiting or diarrhea can rarely lead to dehydration or electrolyte imbalance [5]. MedlinePlus lists early symptoms including agitation, anxiety, muscle aches, insomnia, sweating and yawning [6]. Later ones include abdominal cramping, diarrhea, dilated pupils, goosebumps, nausea and vomiting [6].
Note what this page is not doing. SAMHSA’s onset figures are written per drug, for heroin and for methadone [5]. Stretching one of them across a class the protocol never names would be an invention. Our page on withdrawal symptoms covers the general picture.
One risk is not thin at all. MedlinePlus states that most opioid overdose deaths occur in people who have just detoxed. Withdrawal reduces tolerance, so someone who has just gone through it can overdose on a much smaller amount than before [6]. It also says withdrawal from opiates or opioids on your own can be very hard and may be dangerous [6].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Treatment When a Nitazene Is Involved
Treatment is for the opioid use disorder, not for the analog on the report.
That starts with an assessment. What was used, for how long, and what else is in the picture. What physical and mental health conditions sit alongside it. What has been tried before. A nitazene finding changes the urgency of that talk more than it changes the plan.
Medication is the standard of care. NIDA states that methadone, buprenorphine and naltrexone have been approved by the Food and Drug Administration for the treatment of opioid use disorder [7]. It adds that another medication, lofexidine, has been approved for treatment of withdrawal symptoms [7]. Our page on medication-assisted treatment explains how that model works.
Getting through withdrawal is a start, not a finish. SAMHSA’s protocol states directly that detoxification is not substance abuse treatment and rehabilitation [8]. MedlinePlus puts the same point plainly. Most people need long-term treatment after detox [6]. Medical detox is a level of care. The question worth asking on the first call is what comes after it.
Which level follows is a clinical decision, not a preference. Some people step into residential rehab, and some into an outpatient program. Our explainer on the levels of care sets out what each tier involves. Our guide to getting into rehab describes the order the calls usually happen in, and our treatment centers lists our campuses by state.
Frequently Asked Questions
What are nitazenes? Nitazenes are illicit synthetic opioids. The CDC describes them as a novel group of powerful illicit synthetic opioids derived from 2-benzylbenzimidazole that have been linked to overdose deaths in several states. They were created as a potential pain reliever medication nearly 60 years ago but have never been approved for use in the United States. The DEA calls the class benzimidazole-opioids and says they act on the same receptor as fentanyl and morphine.
Are nitazenes stronger than fentanyl? It depends on which one. The CDC states that laboratory test results indicate the potency of certain nitazene analogs, including isotonitazene, protonitazene and etonitazene, greatly exceeds that of fentanyl, whereas the potency of metonitazene is similar to fentanyl. The CDC publishes no multiplier, and this page does not invent one. Nobody using a drug knows which analog is in it.
Does naloxone work on a nitazene overdose? Yes, with a caveat the CDC states plainly. Naloxone has been effective in reversing nitazene-involved overdoses, but multiple doses might be needed. If someone is unresponsive or has trouble breathing, call 911, give naloxone if it is available, and stay with them until help arrives. For a mental-health crisis, call or text 988. Naloxone is sold over the counter in all 50 states.
Will a standard drug test detect nitazenes? Often not. The CDC says tests for nitazenes are frequently not included in standard toxicology panels and that traditional laboratory panels do not always capture them. That is part of why it expects deaths to be undercounted. This page gives no detection window, because nitazenes are not in the federal detection-period tables this site uses. Ask the program, employer or laboratory what their panel covers.
What does treatment look like after a nitazene overdose? It looks like treatment for opioid use disorder. An assessment comes first, then a level of care and a medication decision. NIDA states that methadone, buprenorphine and naltrexone are approved by the Food and Drug Administration for opioid use disorder, and that lofexidine is approved for withdrawal symptoms. SAMHSA is explicit that detoxification is not substance abuse treatment and rehabilitation, so ask what follows it.
Sources
- Roberts, A., Korona-Bailey, J., & Mukhopadhyay, S. (2022). Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021. Morbidity and Mortality Weekly Report, 71(37), 1196–1197. Centers for Disease Control and Prevention. https://www.cdc.gov/mmwr/volumes/71/wr/mm7137a5.htm
- Drug Enforcement Administration. (2025). Schedules of Controlled Substances: Temporary Placement of Ethyleneoxynitazene, Methylenedioxynitazene, 5-Methyl Etodesnitazene, N-Desethyl Etonitazene, N-Desethyl Protonitazene, N,N-Dimethylamino Etonitazene, and N-Pyrrolidino Isotonitazene in Schedule I. 90 FR 48259. Federal Register. https://www.federalregister.gov/documents/2025/10/15/2025-19542/schedules-of-controlled-substances-temporary-placement-of-ethyleneoxynitazene-methylenedioxynitazene
- Centers for Disease Control and Prevention. (2024). What to Do If You Think Someone Is Overdosing. Stop Overdose. https://www.cdc.gov/stop-overdose/response/index.html
- Centers for Disease Control and Prevention. (2025). Lifesaving Naloxone. Stop Overdose. https://www.cdc.gov/stop-overdose/caring/naloxone.html
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 4: Physical Detoxification Services for Withdrawal From Specific Substances. Treatment Improvement Protocol (TIP) Series No. 45. Substance Abuse and Mental Health Services Administration, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64116/
- MedlinePlus Medical Encyclopedia. Opiate and Opioid Withdrawal. National Library of Medicine. https://medlineplus.gov/ency/article/000949.htm
- National Institute on Drug Abuse. (2025). Fentanyl. National Institutes of Health. https://nida.nih.gov/research-topics/fentanyl
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 1: Overview, Essential Concepts, and Definitions in Detoxification. Treatment Improvement Protocol (TIP) Series No. 45. Substance Abuse and Mental Health Services Administration, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64119/
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
